Drug Manufacturers - General

The Drug Manufacturers - General industry has a total of 20 stocks, with a combined market cap of $3.11 trillion, total revenue of $724.28 billion and a weighted average PE ratio of 21.85.

Market Cap
3.11T
Revenue
724.28B
Profits
142.49B
PE Ratio
21.85
Profit Margin
19.67%
Dividend Yield
2.12%

20 Stocks

No. Symbol Company Name Market Cap % Change Volume Revenue
1LLYEli Lilly and Company650.45B1.39%3,568,05853.26B
2JNJJohnson & Johnson432.80B1.11%8,656,69090.63B
3ABBVAbbVie Inc.389.72B0.95%4,206,21158.33B
4NVONovo Nordisk A/S242.68B-0.77%17,739,50349.11B
5NVSNovartis AG238.65B1.16%915,06255.19B
6AZNAstraZeneca PLC228.75B0.31%4,553,18856.50B
7MRKMerck & Co., Inc.196.23B1.24%12,234,73163.62B
8AMGNAmgen Inc.146.96B0.66%1,818,27934.92B
9GILDGilead Sciences, Inc.139.09B1.00%5,088,75828.86B
10PFEPfizer Inc.135.09B0.68%33,441,00963.83B
11SNYSanofi111.44B1.04%13,182,57653.71B
12BMYBristol-Myers Squibb Company89.80B1.64%15,023,32247.70B
13GSKGSK plc80.21B0.84%4,760,82643.34B
14BIIBBiogen Inc.20.14B1.25%1,675,87010.00B
15GRFSGrifols, S.A.8.51B0.61%531,5148.74B
16OGNOrganon & Co.2.65B0.89%3,191,6706.28B
17AMRNAmarin Corporation plc330.92M3.56%69,541219.36M
18SCLXScilex Holding Company160.58M1.18%269,00244.24M
19MDCXMedicus Pharma Ltd.51.07M6.05%246,501-
20MIRAMIRA Pharmaceuticals, Inc.25.17M1.54%137,951-